Act-A is the most studied isoform in CRC and the findings of several studies have demonstrated paradoxical actions for the protein, a phenomenon known as the “TGF-β paradox” or “molecular switch” [10, 13]. The gene discussed is ACTA1; the disease is colorectal carcinoma.